Randal J. Kirk
Executive ChairmanMr. Randal J. Kirk, also known as RJ, J.D., has been Executive Chairman of Precigen, Inc. since January 01, 2020 and previously served as Chairman of the Board from February 2008 until December 31, 2019. He served as the Chief Executive Officer of Precigen, Inc. (formerly Intrexon Corporation) since April 2009 until December 31, 2019. Mr. Kirk served as President of Precigen, Inc. since April 2009. He served as Acting President of Human Therapeutics Division at Precigen, Inc. until June 2011. Mr. Kirk is Executive Chairman of Third Security, LLC from 2025. He was Senior MD & Chairman of Third Security, LLC until 2025. He was Chief Executive Officer of Third Security, LLC. He founded Third Security, LLC in March 1999. Mr. Kirk has been a Manager at New River Management Company, LLC since 1996. He served as the President and Chief Executive Officer at New River Pharmaceuticals Inc. from October 2001 to April 2007. Mr. Kirk founded New River Pharmaceuticals Inc. in 1996. He began his professional career in the private practice of law. Mr. Kirk co-founded General Injectables & Vaccines, Inc. in 1984. He also co-founded King Pharmaceuticals, Inc. in 1993. He has been the Chairman of the Board at New River Pharmaceuticals Inc. since 1996 and a Director since August 1996. He has been the Chairman of Landmark Scientific, Inc. since 1996. Mr. Kirk serves as the Chairman of Biological & Popular Culture LLC since September 2002 and the Chairman of its predecessor from October 1999 to September 2002. He has been the Chairman Cyntellect Inc. since September 2008. He is a member of the Board of Directors of the Edward via College of Osteopathic Medicine since May 2015. He has been a Director of Michael W. Cook Asset Management, Inc. since January 2003. He has been a Director of Precigen, Inc. since 2008. He has been a Director at Harvest Pharmaceuticals Inc. since December 2002. He served as a Director at ZIOPHARM Oncology, Inc. from January 12, 2011 to October 5, 2018. He was an Independent Director of Halozyme Therapeutics, Inc. since May 2007 until March 2018. He has served on the Virginia Bioinformatics Institute Policy Advisory Board since March 2004. He served as the Chairman of Board for Clinical Data since December 16, 2004 and April 2011. Mr. Kirk served as the Chairman of the Board at GIV prior to the sale of that company in 1998. Mr. Kirk served as the Director of Clinical Data from September 2002 to April 2011. He served as a Director of Scios Inc. from February 2000 until May 15, 2002 and Howe and Rusling, Inc. from December 2001 to 2006. He was on the Governor's Economic Development and Jobs Creation Commission from April 2010 to October 2012. He had been a Member to the Board of Visitors at University of Virginia and Affiliated Schools from July 20, 2009 to October 2012. He served as a member of the Board of Directors of the Virginia University Research Partnership from July 2007 to November 2010. Mr. Kirk served on the Board of Visitors of Radford University since July 2003 to June 2009 and was elected Rector of the Board from September 2006 to September 2008. He Kirk served as a Director of the Radford University Foundation, Inc. from September 1998 to May 2011. He was appointed to the Virginia Advisory Council on Revenue Estimates from July 2006 to October 2012. Mr. Kirk received a JD from the University of Virginia and a BA in Business from Radford University.
Positions
- Company NamePrecigen, Inc.Stock CodePGENPositionExecutive ChairmanColleagues
